Western Health Advantage
Xospata (gilteritinib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: Derm: Acne Vulgaris:
    ST Single Generic

  • Quantity Limit: limit maximum 60 EA PER 30 day(s)
  • Prior Authorization: Endometriosis:
    Documented Diagnosis: Yes
    Duration: 6 Month(s)
    Reauthorization Required: Yes

    Metastatic Prostate Cancer, Non-Metastatic Prostate Cancer, Uterine Fibroids:
    Documented Diagnosis: Yes

  • Reduction of CV events in CAD/PAD:
    Duration: 1 year(s)
    Documented Diagnosis: No
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A